The Increased Risk for Pneumocystis Pneumonia in Patients Receiving Rituximab-CHOP-14 Can Be Prevented by the Administration of Trimethoprim/Sulfamethoxazole: A Single-Center Experience

Publisher： Karger

E-ISSN： 1421-9662|127|2|110-114

ISSN： 0001-5792

Source： Acta Haematologica, Vol.127, Iss.2, 2011-12, pp. : 110-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytomegalovirus infection in high‐risk kidney transplant recipients receiving thymoglobulin induction—a single‐center experience

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 30, Iss. 9, 2016-09 ,pp. : 1159-1164

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose-Dense CHOP plus Rituximab (R-CHOP14) for the Treatment of Elderly Patients with High-Risk Diffuse Large B Cell Lymphoma: A Pilot Study

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 22-27

Karger

Access to resources Recommend Favorite

Trimethoprim-Sulfamethoxazole Exacerbates Posthypoxic Action Myoclonus in a Patient with Suspicion of Pneumocystis jiroveci Infection

By Jundt F.  

Infection, Vol. 32, Iss. 3, 2004-06 ,pp. : 176-178

Springer Publishing Company

Access to resources Recommend Favorite

Switch to atovaquone and subsequent re‐challenge with trimethoprim‐sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 19, Iss. 6, 2017-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Percutaneous Nephrolithotomy in High-Risk Patients: A Single-Center Experience with More than 350 Cases

By  

Urologia Internationalis, Vol. 90, Iss. 4, 2013-04 ,pp. : 394-398

Karger

Access to resources Recommend Favorite